{
  "ticker": "IVG",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02958882",
  "id": "02958882",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250616",
  "time": "1708",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250616/pdf/06ksrjnxjyb4l5.pdf",
  "summary": "- **Director ceased**: Dr David Brookes ceased as director on 16 June 2025.  \n- **Holdings at cessation**:  \n  - Direct: 1,371,250 ordinary shares + 500,000 unlisted options (expiring 12 Oct 2025).  \n  - Indirect (via trusts): 6,030,000 ordinary shares + 1,231,120 unlisted options (expiring 3 June 2030, subject to 24-month trading restrictions).  \n\nNo material trading or capital markets impact identified beyond disclosure of director's interests.",
  "usage": {
    "prompt_tokens": 839,
    "completion_tokens": 120,
    "total_tokens": 959,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-16T07:51:23.424084"
}